HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence.

Abstract
This is the first study contrasting regional glucose metabolic rate (rCMRglu) responses to a serotonergic challenge in major depressive disorder (MDD) with and without comorbid alcohol dependence. In a university hospital, patients with MDD without a history of alcohol dependence (MDD only) and patients with MDD and comorbid alcohol dependence (MDD/ALC) were enrolled in this study. Subjects with comorbid borderline personality disorder were excluded. A bolus injection of approximately 5 mCi of (18)fluorodeoxyglucose was administered 3 h after the administration of placebo or fenfluramine. We found an anterior medial prefrontal cortical area where MDD/ALC subjects had more severe hypofrontality than MDD only patients. This area encompassed the left medial frontal and left and right anterior cingulate gyri. This group difference disappeared after fenfluramine administration. The fact that the observed group difference disappeared after the fenfluramine challenge suggests that serotonergic mechanisms play a role in the observed differences between the groups.
AuthorsLeo Sher, Matthew S Milak, Ramin V Parsey, Juan J Carballo, Thomas B Cooper, Kevin M Malone, Maria A Oquendo, J John Mann
JournalEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology (Eur Neuropsychopharmacol) Vol. 17 Issue 9 Pg. 608-15 (Sep 2007) ISSN: 0924-977X [Print] Netherlands
PMID17478085 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright2007 Elsevier B.V and ECNP
Chemical References
  • Serotonin Uptake Inhibitors
  • Fluorodeoxyglucose F18
  • Fenfluramine
Topics
  • Adult
  • Alcoholism (complications, diagnostic imaging)
  • Brain (drug effects, metabolism)
  • Brain Mapping
  • Depressive Disorder, Major (complications, diagnostic imaging)
  • Female
  • Fenfluramine (pharmacology)
  • Fluorodeoxyglucose F18 (pharmacokinetics)
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Psychiatric Status Rating Scales
  • Selective Serotonin Reuptake Inhibitors (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: